x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

science medicine

All Episodes

52:03

Toxicities Associated with CAR T-Cell Therapy — An...

Hematologic Oncology Update ·

2025/12/04

Dr Matthew Lunning from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on the management of toxicities associated with CAR T-cell therapy.CME information and select publications here.

en

59:42

Patient Education Resource: Non-Hodgkin Lymphoma —...

Hematologic Oncology Update ·

2025/11/15

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Manali Kamdar from the University of Colorado Cancer Center in Aurora discuss patient questions and experiences with CAR T-cell therapy for non-Hodgkin lymphoma.Educational information and select publications here.

en

01:00:13

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma...

Hematologic Oncology Update ·

2025/11/13

Dr Matthew Lunning and Dr Sonali M Smith share their perspectives on the evolving therapeutic landscape for patients with diffuse large B-cell lymphoma and follicular lymphoma.CME information and select publications here.

en

54:59

Acute Myeloid Leukemia — An Interview with Dr Eunice...

Hematologic Oncology Update ·

2025/10/23

Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discusses recent datasets and their implications for the current and future management of acute myeloid leukemia.CME information and select publications here.

en

57:59

Non-Hodgkin Lymphoma — The Implications of Recent...

Hematologic Oncology Update ·

2025/10/18

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, review recent datasets and their significance for the management of various forms of non-Hodgkin lymphoma.CME information and select publications here.

en

59:34

Follicular Lymphoma — Proceedings from a Session Held...

Hematologic Oncology Update ·

2025/10/10

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma. CE information and select publications here.

en

58:47

Acute Myeloid Leukemia — An Interview with Dr Ghayas...

Hematologic Oncology Update ·

2025/10/09

Dr Ghayas Issa from The University of Texas MD Anderson Cancer Center in Houston discusses data guiding the use of menin inhibitors for patients with acute myeloid leukemia and select alterations.CME information and select publications here.

en

58:29

Relapsed/Refractory Multiple Myeloma — Proceedings...

Hematologic Oncology Update ·

2025/10/03

Prof Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel treatment strategies for relapsed/refractory multiple myeloma. CE information and select publications here.

en

53:08

Oncology Nursing Update: Multiple Myeloma — An...

Hematologic Oncology Update ·

2025/09/19

Dr Beth Faiman from Case Comprehensive Cancer Center in Cleveland, Ohio, discusses nursing considerations with CAR T-cell therapy for patients with multiple myeloma.NCPD information and select publications here.

en

54:23

Ocular Toxicities Associated with Antibody-Drug...

Hematologic Oncology Update ·

2025/09/16

Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management.CME information and select publications here.

en

57:47

Ocular Toxicities Associated with Antibody-Drug...

Hematologic Oncology Update ·

2025/09/15

Prof Rebecca A Dent from National Cancer Centre Singapore, Dr Hans Lee from Sara Cannon Research Institute in Nashville, Tennessee, Dr Neel Pasricha from the University of California, San Francisco, and Dr Tiffany A Richards from The University of Texas MD Anderson Cancer Center in Houston, discuss strategies to manage ocular toxicities associated with antibody-drug conjugates and other cancer therapies.CME information and select publications here.

en

54:17

Oncology Nursing Update: Newly Diagnosed Multiple...

Hematologic Oncology Update ·

2025/09/06

Ms Charise Gleason from Emory Healthcare in Atlanta, Georgia, discusses the evolution of first-line therapy for patients with multiple myeloma.NCPD information and select publications here.

en

53:08

Oncology Nursing Update: Newly Diagnosed Multiple...

Hematologic Oncology Update ·

2025/09/05

Prof Xavier Leleu from Poitiers University Hospital in Poitiers, France, discusses nursing considerations in the treatment of newly diagnosed multiple myeloma.NCPD information and select publications here.

en

59:21

Relapsed/Refractory Multiple Myeloma — Oncology Q&A:...

Hematologic Oncology Update ·

2025/08/29

Dr Natalie S Callander and Dr Sagar Lonial provide clinical perspectives on the treatment and disease-management course for patients with relapsed/refractory multiple myeloma.CME information and select publications here.

en

01:02:11

Multiple Myeloma | Oncology Q&A — Patient Education...

Hematologic Oncology Update ·

2025/08/15

For this patient-focused webinar, medical oncologist Dr Neil Love is joined by Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Sagar Lonial from the Winship Cancer Institute of Emory University in Atlanta, Georgia, to discuss the patient experience associated with the diagnosis and treatment of relapsed/refractory multiple myeloma.Educational and faculty information here.

en

43:01

Acute Myeloid Leukemia — An Interview with Dr Jorge...

Hematologic Oncology Update ·

2025/08/12

Dr Jorge Cortes from Georgia Cancer Center at Augusta University discusses patient cases and summarizes current treatment approaches for FLT3- and IDH1/2-mutant acute myeloid leukemia.CME information and select publications here.

en

57:11

Multiple Myeloma — Optimizing the Selection of...

Hematologic Oncology Update ·

2025/08/07

Prof Xavier Leleu and Dr Peter Voorhees review relevant clinical data regarding first-line treatment decisions for patients with multiple myeloma.CME information and select publications here.

en

01:00:43

Chronic Lymphocytic Leukemia — Proceedings from a...

Hematologic Oncology Update ·

2025/07/22

Dr Catherine Coombs and Dr William Wierda summarize major treatment advances in chronic lymphocytic leukemia presented at the 2025 American Society of Clinical Oncology Annual Meeting and review ongoing clinical trials.CME information and select publications here.

en

58:41

Multiple Myeloma — Proceedings from a Webinar Held in...

Hematologic Oncology Update ·

2025/07/18

Dr Ajay K Nooka from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss recent updates on available and novel treatment strategies for multiple myeloma.CME information and select publications here.

en

01:30:22

For Oncology Nurses: Chronic Lymphocytic Leukemia —...

Hematologic Oncology Update ·

2025/07/14

Dr Bita Fakhri, Dr Jeff Sharman, and nurse practitioners Dr Jacqueline Broadway-Duren and Ms Corinne Hoffman discuss the current treatment landscape for chronic lymphocytic leukemia and strategies to mitigate and manage treatment-emergent adverse events.NCPD information and select publications here.

en

613 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter